Article citationsMore>>

J. H. T. Tjhie, A. F. van Belle, M. Dessens-Kroon and D. van Solingen, “Misidentification and Diagnostic Delay Caused by a False-Positive Amplified Mycobacterium Tuberculosis Direct Test in an Immunocompetent Patient with a Mycobacterium Celatum Infection,” Journal of Clinical Microbiology, Vol. 39, No. 6, 2001, pp. 2311-2312.
http://dx.doi.org/10.1128/JCM.39.6.2311-2312.2001

has been cited by the following article:

• TITLE: Fatal Pulmonary Mycobacterium Celatum Infection in an Immunocompetent Patient. An Eight-Year Follow-Up of the First Case, a Review of the Literature and a Report of Beta-2 Microglobulin as a Potential Indicator of Disease Severity

  AUTHORS: S. Rustscheff, J. Darelid

  KEYWORDS: Mycobacterium Celatum; Immunocompenent

  JOURNAL NAME: Advances in Infectious Diseases, Vol.3 No.4, December 3, 2013

  ABSTRACT: Setting: Swedish county hospital. Objective: Pulmonary M. celatum infection has been previously described only twice in an immunocompetent individual with no pre-existing chest disease. We describe the first Swedish case report of unusual drug-related complications and review the literature. Discussion: Atypical mycobacteriosis is often difficult to treat. We describe a fatal case of m celatum pneumonia in a previously healthy patient, unusual side effects encountered during her treatment and also the report of the utility of beta-2-microglobulin as a way to measure disease activity in mycobacterial infections. Conclusions: M. celatum may cause fatal pneumonia in previously healthy individuals. Treating the disease may be fraught with difficulty and there is a risk for very severe side effects, all of which must be weighed before taking the decision to treat this disease.